ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF
The present disclosure provides an anti-PD-L1 /anti-LAG3 bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between LAG3 and its ligand (e.g., a MHC class II molecule and FGL1). The bispecific antibody may have high binding affinity to both of a...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LEE, Yangsoon PARK, Eunyoung YOU, Weon-Kyoo KIM, Yeun Ju PAK, Youngdon FANG, Lei JUNG, Uijung LEE, Sang Hoon JUNG, Jaeho KIM, YoungKwang JIANG, Wenqing |
| description | The present disclosure provides an anti-PD-L1 /anti-LAG3 bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between LAG3 and its ligand (e.g., a MHC class II molecule and FGL1). The bispecific antibody may have high binding affinity to both of a PD-L1 protein (e.g., a human PD-L1 protein) and a LAG3 protein (e.g., a human LAG3 protein). Also provided are antibodies and fragments that have specificity to the PD-L1 or LAG3 protein alone, or antibodies and fragments having additional specificity to one or more other antigens. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4249511A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4249511A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4249511A33</originalsourceid><addsrcrecordid>eNrjZLB29Avx1A1w0fUx1AczfRzdjRWcPIMDXJ093TydFUCCTv4unq7BQKaLQmgwkBHi4Rrk6u_Gw8CalphTnMoLpbkZFNxcQ5w9dFML8uNTiwsSk1PzUkviXQNMjEwsTQ0NHY2NiVACAEjfKFs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF</title><source>esp@cenet</source><creator>LEE, Yangsoon ; PARK, Eunyoung ; YOU, Weon-Kyoo ; KIM, Yeun Ju ; PAK, Youngdon ; FANG, Lei ; JUNG, Uijung ; LEE, Sang Hoon ; JUNG, Jaeho ; KIM, YoungKwang ; JIANG, Wenqing</creator><creatorcontrib>LEE, Yangsoon ; PARK, Eunyoung ; YOU, Weon-Kyoo ; KIM, Yeun Ju ; PAK, Youngdon ; FANG, Lei ; JUNG, Uijung ; LEE, Sang Hoon ; JUNG, Jaeho ; KIM, YoungKwang ; JIANG, Wenqing</creatorcontrib><description>The present disclosure provides an anti-PD-L1 /anti-LAG3 bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between LAG3 and its ligand (e.g., a MHC class II molecule and FGL1). The bispecific antibody may have high binding affinity to both of a PD-L1 protein (e.g., a human PD-L1 protein) and a LAG3 protein (e.g., a human LAG3 protein). Also provided are antibodies and fragments that have specificity to the PD-L1 or LAG3 protein alone, or antibodies and fragments having additional specificity to one or more other antigens.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240110&DB=EPODOC&CC=EP&NR=4249511A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240110&DB=EPODOC&CC=EP&NR=4249511A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LEE, Yangsoon</creatorcontrib><creatorcontrib>PARK, Eunyoung</creatorcontrib><creatorcontrib>YOU, Weon-Kyoo</creatorcontrib><creatorcontrib>KIM, Yeun Ju</creatorcontrib><creatorcontrib>PAK, Youngdon</creatorcontrib><creatorcontrib>FANG, Lei</creatorcontrib><creatorcontrib>JUNG, Uijung</creatorcontrib><creatorcontrib>LEE, Sang Hoon</creatorcontrib><creatorcontrib>JUNG, Jaeho</creatorcontrib><creatorcontrib>KIM, YoungKwang</creatorcontrib><creatorcontrib>JIANG, Wenqing</creatorcontrib><title>ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF</title><description>The present disclosure provides an anti-PD-L1 /anti-LAG3 bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between LAG3 and its ligand (e.g., a MHC class II molecule and FGL1). The bispecific antibody may have high binding affinity to both of a PD-L1 protein (e.g., a human PD-L1 protein) and a LAG3 protein (e.g., a human LAG3 protein). Also provided are antibodies and fragments that have specificity to the PD-L1 or LAG3 protein alone, or antibodies and fragments having additional specificity to one or more other antigens.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB29Avx1A1w0fUx1AczfRzdjRWcPIMDXJ093TydFUCCTv4unq7BQKaLQmgwkBHi4Rrk6u_Gw8CalphTnMoLpbkZFNxcQ5w9dFML8uNTiwsSk1PzUkviXQNMjEwsTQ0NHY2NiVACAEjfKFs</recordid><startdate>20240110</startdate><enddate>20240110</enddate><creator>LEE, Yangsoon</creator><creator>PARK, Eunyoung</creator><creator>YOU, Weon-Kyoo</creator><creator>KIM, Yeun Ju</creator><creator>PAK, Youngdon</creator><creator>FANG, Lei</creator><creator>JUNG, Uijung</creator><creator>LEE, Sang Hoon</creator><creator>JUNG, Jaeho</creator><creator>KIM, YoungKwang</creator><creator>JIANG, Wenqing</creator><scope>EVB</scope></search><sort><creationdate>20240110</creationdate><title>ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF</title><author>LEE, Yangsoon ; PARK, Eunyoung ; YOU, Weon-Kyoo ; KIM, Yeun Ju ; PAK, Youngdon ; FANG, Lei ; JUNG, Uijung ; LEE, Sang Hoon ; JUNG, Jaeho ; KIM, YoungKwang ; JIANG, Wenqing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4249511A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LEE, Yangsoon</creatorcontrib><creatorcontrib>PARK, Eunyoung</creatorcontrib><creatorcontrib>YOU, Weon-Kyoo</creatorcontrib><creatorcontrib>KIM, Yeun Ju</creatorcontrib><creatorcontrib>PAK, Youngdon</creatorcontrib><creatorcontrib>FANG, Lei</creatorcontrib><creatorcontrib>JUNG, Uijung</creatorcontrib><creatorcontrib>LEE, Sang Hoon</creatorcontrib><creatorcontrib>JUNG, Jaeho</creatorcontrib><creatorcontrib>KIM, YoungKwang</creatorcontrib><creatorcontrib>JIANG, Wenqing</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LEE, Yangsoon</au><au>PARK, Eunyoung</au><au>YOU, Weon-Kyoo</au><au>KIM, Yeun Ju</au><au>PAK, Youngdon</au><au>FANG, Lei</au><au>JUNG, Uijung</au><au>LEE, Sang Hoon</au><au>JUNG, Jaeho</au><au>KIM, YoungKwang</au><au>JIANG, Wenqing</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF</title><date>2024-01-10</date><risdate>2024</risdate><abstract>The present disclosure provides an anti-PD-L1 /anti-LAG3 bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between LAG3 and its ligand (e.g., a MHC class II molecule and FGL1). The bispecific antibody may have high binding affinity to both of a PD-L1 protein (e.g., a human PD-L1 protein) and a LAG3 protein (e.g., a human LAG3 protein). Also provided are antibodies and fragments that have specificity to the PD-L1 or LAG3 protein alone, or antibodies and fragments having additional specificity to one or more other antigens.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4249511A3 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-07T06%3A29%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LEE,%20Yangsoon&rft.date=2024-01-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4249511A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |